Organogenesis Holdings Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 433.14 million compared to USD 450.89 million a year ago. Net income was USD 4.95 million compared to USD 15.53 million a year ago.

Basic earnings per share from continuing operations was USD 0.04 compared to USD 0.12 a year ago. Diluted earnings per share from continuing operations was USD 0.04 compared to USD 0.12 a year ago.